Galectin Therapeutics (GALT) Insider Trading & Ownership $1.24 -0.01 (-0.80%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Galectin Therapeutics (NASDAQ:GALT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage50.10%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)$48,945.70Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$162,703.90 Get GALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Galectin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address GALT Insider Buying and Selling by Quarter Galectin Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/30/2024Harold H ShlevinDirectorBuy6,500$1.16$7,540.00 12/24/2024Richard A Jr. ZordaniDirectorBuy10,000$0.82$8,200.00 12/23/2024Jack W CallicuttCFOSell40,000$0.89$35,600.00 12/23/2024Joel LewisCEOSell56,000$0.89$49,840.00 12/23/2024Khurram JamilInsiderSell13,654$0.88$12,015.52 10/23/2024Kary EldredDirectorBuy500$2.60$1,300.00 10/16/2024Kevin D FreemanDirectorBuy5,000$2.70$13,500.00 8/23/2024Richard A Jr. ZordaniDirectorBuy1,759$2.30$4,045.70 4/30/2024Richard A Jr. ZordaniDirectorBuy1,000$3.52$3,520.00 4/24/2024Joel LewisCEOBuy1,000$3.39$3,390.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/22/2024James C CzirrMajor ShareholderSell21,323$3.06$65,248.38 4/22/2024Kevin D FreemanDirectorBuy2,500$2.98$7,450.00 (Data available from 1/1/2013 forward) GALT Insider Trading Activity - Frequently Asked Questions Who is on Galectin Therapeutics's Insider Roster? The list of insiders at Galectin Therapeutics includes Elissa J Schwartz, Fund L.P. 10X, Harold H Shlevin, Jack W Callicutt, James C Czirr, Joel Lewis, Kary Eldred, Kevin D Freeman, Khurram Jamil, and Richard A Jr. Zordani. Learn more on insiders at GALT. What percentage of Galectin Therapeutics stock is owned by insiders? 50.10% of Galectin Therapeutics stock is owned by insiders. Learn more on GALT's insider holdings. Which Galectin Therapeutics insiders have been buying company stock? The following insiders have purchased GALT shares in the last 24 months: Harold H Shlevin ($7,540.00), Joel Lewis ($4,910.00), Kary Eldred ($8,088.42), Kevin D Freeman ($20,950.00), and Richard A Jr. Zordani ($15,765.70). How much insider buying is happening at Galectin Therapeutics? Insiders have purchased a total of 33,657 GALT shares in the last 24 months for a total of $57,254.12 bought. Which Galectin Therapeutics insiders have been selling company stock? The following insiders have sold GALT shares in the last 24 months: Jack W Callicutt ($35,600.00), James C Czirr ($65,248.38), Joel Lewis ($49,840.00), and Khurram Jamil ($12,015.52). How much insider selling is happening at Galectin Therapeutics? Insiders have sold a total of 130,977 Galectin Therapeutics shares in the last 24 months for a total of $162,703.90 sold. Galectin Therapeutics Key ExecutivesMr. Joel Lewis (Age 54)President, CEO & Director Compensation: $907.72k1 recent tradesMr. Jack W. Callicutt CPA (Age 57)CFO, Treasurer & Corporate Secretary Compensation: $521.47k1 recent tradesDr. Pol F. Boudes M.D. (Age 67)Ph.D., Chief Medical Officer Compensation: $730.33kRobert TrittGeneral CounselMr. Jeff KatstraHead of CMC & Pharmaceutical DevelopmentMs. Beth KnowlesExecutive Assistant & Officer Manager More Insider Trading Tools from MarketBeat Related Companies Olema Pharmaceuticals Insider Transactions Rezolute Insider Transactions Compass Therapeutics Insider Transactions Neurogene Insider Transactions Atea Pharmaceuticals Insider Transactions Canopy Growth Insider Transactions Candel Therapeutics Insider Transactions Benitec Biopharma Insider Transactions C4 Therapeutics Insider Transactions Foghorn Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:GALT) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galectin Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galectin Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GALT Stock Alerts